LSPedia Newsletter

DSCSA Enforcement Begins May 27 – 6 Critical Actions to Protect Your Shipments ‍FDA enforcement is around the corner. LSPedia outlines six key actions—like validating EPCIS connections and resolving exceptions—to help manufacturers and repackagers stay compliant and keep shipments moving.

LSPedia’s Daniel MacKinnon met with leading pharma manufacturers in India frustrated by outdated systems and poor support. His latest blog explains why many are making the switch to LSPedia.

Discover how Baptist Health transformed compliance and operational workflows with LSPedia’s OneScan Suite.

Matt Vincent, Director of Sales at LSPedia, breaks down the FDA’s DSCSA exemptions and their importance as the stabilization period ends on November 27, 2024.

LSPedia is excited to introduce the new WEE Management Module as part of the upcoming OneScan 7.3 release on October 6, 2024.

LSPedia has introduced a new Waivers, Exceptions, and Exemptions (WEEs) resource page, providing essential answers to pressing questions from those considering requesting a waiver for additional time to achieve DSCSA compliance and how to manage WEEs going forward with trading partners.

In the pharmaceutical industry, maintaining a resilient and sustainable supply chain is paramount for ensuring product integrity, regulatory compliance, and operational efficiency.

LSPedia launched OneScan 7.1, a leading traceability solution trusted by major healthcare brands globally.

Stay on track with DSCSA compliance new year. In this edition we talk about exciting news about LSPedia's selection to Veteran Affairs and much more

The DSCSA deadline is almost here. In this edition we are talking about our partnership with Redsail and much more

Welcome to our compliance update, click on the link to read more